Causes of Dermatomyositis
Dermatomyositis is an idiopathic autoimmune disease with an unknown primary cause, but results from a complex interplay of genetic predisposition, environmental triggers, and immune dysregulation, particularly involving complement-mediated vasculopathy and type I interferon pathway activation 1.
Pathogenic Mechanisms
The disease fundamentally represents a complement-mediated vasculopathy of small vessels in muscle tissue, leading to ischemia and vessel damage 1. The pathogenesis involves:
- Deposition of C5b-9 membrane attack complex around the microvasculature
- Perifascicular atrophy from tissue hypoperfusion due to ischemic microangiopathy
- Type I interferon (α/β) pathway activation as a central inflammatory mechanism 1
- Infiltration of plasmacytoid dendritic cells, B cells, and CD4+ T cells in perimysial and perivascular areas
Genetic Susceptibility
Certain HLA alleles confer increased risk 1:
- HLA-DQA1*0501
- HLA-DRB1*0301
- TNF-α (TNFα-308A) polymorphisms - associated with longer disease course, increased severity, and calcinosis in juvenile dermatomyositis
Environmental Triggers
Multiple environmental factors can precipitate disease in genetically susceptible individuals:
Infectious Agents
- Viral infections, particularly Coxsackie B virus, may trigger immune dysregulation 1
- Cytomegalovirus (CMV) infection occurs frequently in DM patients (29.2% prevalence) 2
Medications
- Statins (HMG-CoA reductase inhibitors) can trigger immune-mediated necrotizing myopathy with anti-HMGCR antibodies 1, 3
- D-penicillamine
- NSAIDs
- Anti-infectious agents 3
Occupational and Environmental Exposures
- Maternal occupational exposure to inhalable agents (OR = 17.88) is a significant risk factor 4
- Ozone (O3) exposure in the fifth year of life (third tertile > 86.28µg/m³; OR = 6.53) 4
- Air pollutants including PM10, SO2, NO2, and CO may play a role 4
Malignancy Association
Dermatomyositis has the highest cancer association among all inflammatory myopathies, with risk more than double that of other subtypes 5. This represents a bidirectional relationship:
- 20% of adult DM cases are paraneoplastic 6
- Cancer risk is greatest within 3 years before or after DM onset 7, 8
- Most common associated malignancies: ovarian, lung, breast, pancreatic, stomach, hematologic, and colorectal cancers 8
Risk Factors for Cancer-Associated DM
High-risk features include 5:
- Anti-TIF1γ antibody positivity (RR 4.68 - over 4 times higher cancer risk)
- Age ≥40 years at DM onset (P = 0.001) 5, 7
- Persistent high disease activity despite immunosuppression
- Treatment-refractory dysphagia
- Cutaneous necrosis and/or ulceration
Autoantibody-Defined Phenotypes
Myositis-specific antibodies define distinct DM subsets with different clinical profiles and prognoses 1, 9:
- Anti-MDA5: Associated with rapidly progressive interstitial lung disease and higher CMV infection rates (38.7% vs 16.0%, P = 0.001) 2
- Anti-Mi2: Classic DM phenotype
- Anti-NXP2: Increased cancer risk (though lower than anti-TIF1γ)
- Anti-SAE: Distinct cutaneous manifestations
Clinical Pitfalls
Important caveats to recognize:
Drug-induced DM is rare and unpredictable in individual patients but should be considered when statins or other triggering medications are involved 3
Prematurity and gestational exposures (cigarette smoke, air pollutants during pregnancy) have NOT been consistently associated with DM development or disease course 4
The term "idiopathic" remains appropriate because no single causative agent has been identified - the disease represents a final common pathway from multiple potential triggers in susceptible individuals 1, 6
Environmental factors appear more relevant in juvenile DM than previously recognized, particularly maternal occupational exposures and childhood ozone exposure 4